Simon Burton, Author at PBD Biotech

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022

A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the...

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022

A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that...

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022

This is the first time Actiphage has been used to detect MAP in a human blood sample and also to identify a live infection in a vaccinated goat.

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022

This is the first time Actiphage has been used to detect MAP in a human blood sample and also to...

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022

Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022

Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria...

12 -16th June 2022

ICP 2022

May 26, 2022

The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International Association for Paratuberculosis Colloquium (ICP2022) in Dublin on 12 – 16th June 2022.

12 -16th June 2022

ICP 2022

May 26, 2022

The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International...

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022

The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022

The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of...

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022

A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022

A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022

A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the bacteria that causes Johne's Disease an economically devastating disease.

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022

A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk...

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022

PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the cause of Johne's Disease